๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
XBiotech Inc. (XBIT)
NASDAQ: XBIT ยท Real-Time Price ยท USD
1.730
+0.050 (2.98%)
At close: Nov 20, 2026, 4:00 PM EST
1.740
+0.010 (0.58%)
After-hours: Nov 20, 2026, 7:30 PM EST

XBiotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----4.0118.39
Revenue Growth
-----78.20%-58.19%
Gross Profit
----3.3612.57
Operating Income
-47.49-55.69-42.47-37.51-34.49-25.08
Net Income
-43.59-45.54-38.53-24.56-32.9-17.41
Earnings Per Share
-1.43-1.49-1.26-0.81-1.08-0.58
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
105.04125.55172.68200.02217.48236.98
Total Debt
--10.25---
Net Cash (Debt)
105.04125.55162.43200.02217.48236.98
Net Cash Growth
-28.72%-22.70%-18.80%-8.03%-8.23%-0.16%
Net Cash Per Share
3.454.125.336.577.147.89

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.96-39.92-30.96-18.73-14.8269.45
Capital Expenditures
-0.05-0.29-1.3-0.36-0.59-3.53
Free Cash Flow
-41-40.21-32.27-19.09-15.4165.92
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----83.77%68.36%
Operating Margin
-----860.10%-136.36%
Pretax Margin
-----837.61%-138.40%
Profit Margin
-----820.45%-94.67%
FCF Margin
-----384.26%358.38%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-87.6387.6387.6387.6387.63
P/FCF Ratio
-----5.13
PS Ratio
----26.6418.39